Zoetis Inc. (ZTS): Price and Financial Metrics

Zoetis Inc. (ZTS)

Today's Latest Price: $157.72 USD

2.08 (1.34%)

Updated Aug 5 8:04pm

Add ZTS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZTS Stock Summary

  • With a market capitalization of $73,919,781,754, Zoetis Inc has a greater market value than 97.49% of US stocks.
  • The price/operating cash flow metric for Zoetis Inc is higher than 90.82% of stocks in our set with a positive cash flow.
  • In terms of volatility of its share price, ZTS is more volatile than only 4.41% of stocks we're observing.
  • Stocks that are quantitatively similar to ZTS, based on their financial statements, market capitalization, and price volatility, are PKI, GNRC, BDC, IBM, and BDX.
  • Visit ZTS's SEC page to see the company's official filings. To visit the company's web site, go to www.zoetis.com.
ZTS Daily Price Range
ZTS 52-Week Price Range

ZTS Stock Price Chart Technical Analysis Charts

ZTS Price/Volume Stats

Current price $157.72 52-week high $158.37
Prev. close $155.64 52-week low $90.14
Day low $155.78 Volume 1,599,300
Day high $158.37 Avg. volume 2,292,113
50-day MA $140.76 Dividend yield 0.51%
200-day MA $130.89 Market Cap 74.91B

Zoetis Inc. (ZTS) Company Bio

Zoetis Inc. discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. The company was founded in 1952 and is based in Florham Park, New Jersey.

ZTS Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$157.72$79.74 -49%

Below please find a table outlining a discounted cash flow forecast for ZTS, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Zoetis Inc ranked in the 32th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for ZTS, they are:

  • The company has produced more trailing twelve month cash flow than 80.95% of its sector Healthcare.
  • The business' balance sheet suggests that 8% of the company's capital is sourced from debt; this is greater than just 20.19% of the free cash flow producing stocks we're observing.
  • ZTS's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 40.48% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

ENTA, PRAH, ESMC, IONS, and LCI can be thought of as valuation peers to ZTS, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

ZTS Latest News Stream

Event/Time News Detail
Loading, please wait...

ZTS Latest Social Stream

Loading social stream, please wait...

View Full ZTS Social Stream

Latest ZTS News From Around the Web

Below are the latest news stories about Zoetis Inc that investors may wish to consider to help them evaluate ZTS as an investment opportunity.

The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Medpace Holdings Inc (NASDAQ: MEDP ) (saw an extension of its earnings-induced momentum) NeoGenomics, Inc. (NASDAQ: NEO )(reacted to its second-quarter results) OncoSec Medical Inc (NASDAQ: ONCS ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Trevena Inc (NASDAQ: TRVN ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 28) Nkarta Inc (NASDAQ: NKTX ) Nurix Therapeutics Inc (NASDAQ: NRIX )(IPOed Friday) Verrica Pharmaceuticals Inc (NASDAQ:...

Benzinga | July 29, 2020

Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | July 21, 2020

Zoetis (ZTS) Hits 52-Week High, Can the Run Continue?

Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Yahoo | July 21, 2020

Is Elanco Stock a Buy?

Despite mediocre financial results, could a major upcoming acquisition be what this company needs to succeed?

Yahoo | July 18, 2020

Dow Holds 650-Point Weekly Gain; Why Ericsson, Wingstop, Zoetis Hit Buy Points Today

The Dow Jones Industrial Average had trouble padding its recent gains, yet the action in stocks today points to a market in a confirmed uptrend. While the Dow's opening gain of 0.3% was much smaller than some of its strong daily increases, and eroded during the first hour of trading, the 30-stock blue chip index continues to stay at five-week highs. At this week's high of 27,071, the Dow industrials have now risen 48% off the coronavirus stock market crash low of 18,213.

Yahoo | July 17, 2020

Read More 'ZTS' Stories Here

ZTS Price Returns

1-mo 13.95%
3-mo 27.13%
6-mo 13.89%
1-year 30.91%
3-year 158.58%
5-year 238.41%
YTD 19.70%
2019 55.71%
2018 19.45%
2017 35.55%
2016 12.64%
2015 12.18%

ZTS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZTS Dividend History

Continue Researching ZTS

Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:

Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9254 seconds.